Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

Gaps in ambulatory patient safety for immunosuppressive specialty medications.

Patterson S, Schmajuk G, Evans M, et al. Gaps in Ambulatory Patient Safety for Immunosuppressive Specialty Medications. Jt Comm J Qual Patient Saf. 2019;45(5):348-357. doi:10.1016/j.jcjq.2018.12.003.

Save
Print
June 12, 2019
Patterson S, Schmajuk G, Evans M, et al. Jt Comm J Qual Patient Saf. 2019;45(5):348-357.
View more articles from the same authors.

This retrospective cohort study sought to determine whether screening for tuberculosis and hepatitis B and C was consistently performed prior to initiating immunosuppressive medications. About a quarter of patients were appropriately screened for all three infections before starting these high-risk medications, demonstrating the need for safety protocols regarding provision of immunosuppressive medication.

Save
Print
Cite
Citation

Patterson S, Schmajuk G, Evans M, et al. Gaps in Ambulatory Patient Safety for Immunosuppressive Specialty Medications. Jt Comm J Qual Patient Saf. 2019;45(5):348-357. doi:10.1016/j.jcjq.2018.12.003.